From Breast Cancer to Antimicrobial: Combating Extremely Resistant Gram-Negative "Superbugs" Using Novel Combinations

Maytham H Hussein1, Elena K Schneider1, Alysha G Elliott2

  • 11 Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University , Parkville, Australia .

Microbial Drug Resistance (Larchmont, N.Y.)
|December 10, 2016
PubMed

Insights

Novel therapies combining polymyxin B with selective estrogen receptor modulators (SERMs) show synergistic antibacterial activity against extremely drug-resistant Gram-negative pathogens. This combination offers a promising strategy for treating infections caused by these challenging "superbugs".

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Pharmacology

Background:

  • Extremely drug-resistant (XDR) Gram-negative pathogens, or "superbugs," pose a significant threat, necessitating novel therapeutic strategies.
  • Polymyxin B is a last-resort antibiotic, but resistance is increasing, limiting its clinical utility.
  • Selective estrogen receptor modulators (SERMs) have not been extensively explored for their direct antibacterial properties or synergistic potential.

Purpose of the Study:

  • To investigate the synergistic antibacterial activity of polymyxin B in combination with SERMs against problematic Gram-negative pathogens.
  • To evaluate the efficacy of this combination against polymyxin-resistant isolates of Pseudomonas aeruginosa, Klebsiella pneumoniae, and Acinetobacter baumannii.

Main Methods:

  • In vitro assessment of synergistic activity using microdilution checkerboard and static time-kill assays.
  • Evaluation of bacterial killing, biofilm inhibition, membrane depolarization, and reactive oxygen species generation.
  • Microscopic analysis (scanning and transmission electron microscopy) to observe cellular damage.

Main Results:

  • Polymyxin B and SERMs (tamoxifen, raloxifene, toremifene) were ineffective as monotherapy against polymyxin-resistant Gram-negative bacteria.
  • Combination therapy demonstrated synergistic killing, reducing bacterial counts by ≥2-3 log10 CFU/ml after 24 hours.
  • Polymyxin B with toremifene showed potent activity against P. aeruginosa biofilms and induced significant membrane damage and cellular stress.

Conclusions:

  • The combination of polymyxin B and SERMs exhibits significant synergistic activity against XDR Gram-negative pathogens, including polymyxin-resistant strains.
  • This novel combination therapy strategy holds promise for treating infections caused by difficult-to-treat Gram-negative bacteria.
  • Further research into this combination could lead to new treatment options for nosocomial infections.

Related Concept Videos

Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.8K
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
1.6K
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
820
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
60
Antibiotic Selection00:57

Antibiotic Selection

Overview
61.8K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
7.1K